As of yesterday, that vaccine candidate is in human trials in Bethesda, Maryland -- in a study being run by the US NIH. Here's a bit, from Medical Xpress:
. . . .The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
The study, which is being conducted at the NIH Clinical Center in Bethesda, Maryland, will examine the experimental vaccine's safety and ability to generate an immune response. . . .
I wish you all -- of good will -- nothing but the best, in all things. Do treat others as you would wish to be treated. . . smile. With this candidate, we are all our brothers' and sisters' keepers. . . . regardless of geopolitical borders.